LivaNova (LIVN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices - ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received 510(k) clearance for extracorporeal membrane oxygenation ...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2025 results on Wed., Aug. 6, 2025, at 1 ...

You may recall that I, back in July (about 4-5 months ago), provided an introductory thesis on LivaNova (LIVN). The company was a "BUY" according to me, and I even bought a small stake, making it part ...

LivaNova (NASDAQ:LIVN) reported first-quarter 2026 results that management said reflected “durable performance” across its ...

While LivaNova PLC (NASDAQ:LIVN) might not be the most widely known stock at the moment, it saw a significant share price rise of over 20% in the past couple of months on the NASDAQGS. With many ...

LivaNova (NASDAQ:LIVN) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below provides a concise overview of ...

LivaNova provides high-tech medical devices for the benefit of healthcare professionals, patients, and healthcare systems around the world. Considering the geographic diversification of the business ...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know ...

LivaNova (LIVN) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.85 per share. This compares to earnings of $0.88 per share a year ago. These figures are ...